Gsk Share Discussion Threads

[tradermichael] 08/5/2019 09:24

Reality, buy shares on 1 Jan 1995 at 618p

Hold and collect dividends, total dividends: 1430

Profit (by today) is 1430-618 = 800p, with your shares owing you 0p

[montyhedge] 08/5/2019 09:19

That's why I say this like owning a corporate bond, but with more risk, yes income but no shareprice growth.

[montyhedge] 08/5/2019 09:17

Yes but no growth in 22 years.

[tradermichael] 08/5/2019 09:08

My figures are:

Total dividends paid out
since 2000: 1234p
since Mar 1998: 1342p
Since Sep 1995: 1430p

[tradermichael] 08/5/2019 08:41

OK, and the total dividends paid out in that period, please?

[gordogecks] 07/5/2019 22:11

Let's assess the facts.

2002 GSK £16.34
2019 GSK £15.17

H £20.94 Jan 1999
Range bound 2002 onwards.


Monty correct - no growth since 2002.
22 years ago is 1997.

Price in 1997 was:
£14.05 Dec 1997. A high?


So essentially range bound since 1997 with a two year peak 2000-2001

[alphorn] 07/5/2019 13:43

They were over £20; max around £23???

[montyhedge] 07/5/2019 13:38

Below the price their 22 years ago when they were 1550p. No growth whatsoever in GSK.

[cityfarmer] 03/5/2019 20:20

BREAKING: GlaxoSmithKline Hit With $89.7M Verdict For Inhaler IP
Law360 (May 3, 2019, 1:46 PM EDT) -- A federal jury in Delaware found Friday that GlaxoSmithKline LLC and Glaxo Group Ltd. owe $89.7 million to U.K.-based Vectura Ltd. for infringing a single claim of a patent covering features...

[alphorn] 03/5/2019 09:33

Coupled with the above post - where is the cash geographically versus the point of payment of dividends? (Relevant to many global companies).

[philanderer] 03/5/2019 09:30

Morning everyone , ticking along nicely.

Glaxo struggles with cash conversion


GlaxoSmithKline (GSK) has delivered profits ahead of expectations but it is still struggling to turn them into cash, says Hargreaves Lansdown.

First quarter product sales rose 5% to £7.7 billion boosted by strong results in pharmaceuticals and vaccines, as well as success with a new respiratory treatment.

‘However, GSK has again struggled to turn profits into cash, an area where it’s a serial offender,’ said analyst Nicholas Hyett.

‘Cash conversion has deteriorated significantly, partly down to timing, but also because headline profitability is being flattered by revaluations that don’t turn up in the all-important cashflow statement.’

Hyett said investors should give the pharma giant ‘the benefit of the doubt, at least for now’, as product launches have performed well and the labs are busy.

[tradermichael] 03/5/2019 08:32

The merger and subsequent divestment of the Consumer Healthcare business will herald a new era for the company …. ;0)

[montyhedge] 03/5/2019 08:28

Price below what it was 22 years ago, it's a income stock and not a growth share, it's like having a corporate bond but with more risk. Wonder if it will be this price in 22 years time.

[abdullla] 02/5/2019 15:55

So now it's all up to the rats,the ball is in their court.

[porsche1945] 02/5/2019 14:30

Yeah thats exactly what we are wishing for, a plague, that only gsk have the cure for and we all cash out with huge profits at 50 quid a share bwahaha

[abdullla] 02/5/2019 13:30

All agreed,just testing.

[montyhedge] 02/5/2019 11:57

Of course without shareholders no life saving drugs, no pharma companies.

[tradermichael] 02/5/2019 11:55

GSK's 150 year history has brought improved health to and saved the lives of millions of people worldwide, enabling them to "Do more, feel better live longer".

As shareholders, supporting this quest, its never unreasonable to expect an investment return.

[steeplejack] 02/5/2019 11:13

No investor has to wish for nasty illnesses.A rising global population and increased longevity pretty much assures rising demand for medication.

[abdullla] 02/5/2019 07:56

Are the investors wishing a world full of nasty diseases so they can see their pharma share price shooting up and up,sad very sad indeed.

[montyhedge] 02/5/2019 07:53

1997 average shareprice 1581p, 22 years later 1550p.Wow that's some growth, lol.Sogosit, still got Micro Focus, glad I sold 2540p.

[sogoesit] 02/5/2019 07:05

Usual carp from monty who cannot subtract 25 from 2018 and look up what that year's share price was.
Hey, monty, best trader on advfn who can't read a share price chart!
Lol!

[buywell3] 02/5/2019 07:01

Alzheimer's can be caught .... It's a transmissible disease


Alzheimer's disease is a 'double-prion disorder'

Self-propagating amyloid and tau prions found in post-mortem brain samples, with highest levels in patients who died young

May 1, 2019


“I believe this shows beyond a shadow of a doubt that amyloid beta and tau are both prions, and that Alzheimer’s disease is a double-prion disorder in which these two rogue proteins together destroy the brain,” said Stanley Prusiner, MD, the study’s senior author and director of the UCSF Institute for Neurodegenerative Diseases, part of the UCSF Weill Institute for Neurosciences.

“The fact that prion levels also appear linked to patient longevity should change how we think about the way forward for developing treatments for the disease.


Over the past decade, laboratory studies at UCSF and elsewhere have begun to show that amyloid plaques and tau tangles from diseased brains can infect healthy brain tissue much like PrP, but considerably more slowly.

[crossing_the_rubicon] 01/5/2019 19:55

Transcript and slides for anyone so disposed...

GlaxoSmithKline plc (GSK) CEO Emma Walmsley on Q1 2019 Results - Earnings Call Transcript



GlaxoSmithKline plc 2019 Q1 - Results - Earnings Call Slides

[montyhedge] 01/5/2019 19:20

Oh really, that's ok for you and me, but a lot of investors just buy and hold.GSK shareprice is below what they where 25 years ago. More a bond than a share.